Forte Biosciences Inc (FBRX)

Finanzdaten der Forte Biosciences Inc-Aktie (FBRX)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00% -	1.124	-	-	-
Operating Expenses	22.30% 7.804	6.381	10.22	9.034	6.855
Operating Income/Loss	22.30% -7.804	-6.381	-10.22	-9.034	-6.855
Income/Loss From Continuing Operations Before Tax	127.76% -7.42	26.73	-9.955	-8.896	-6.753
Income/Loss From Continuing Operations After Tax	26.36% -7.42	-5.872	-9.955	-8.896	-6.753
Net Income/Loss	26.36% -7.42	-5.872	-9.955	-8.896	-6.753
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Earnings Per Share	300.00% -0.16	-0.04	-0.26	-0.42	-0.32
Diluted Earnings Per Share	300.00% -0.16	-0.04	-0.26	-0.42	-0.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-